Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-619-1 | CAS number: 144-19-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6-hour exposure followed by 14-day observation period
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted prior to introduction of Good Laboratory Practices; data from a summary report; limited number of animals. Study was conducted by an internal Eastman Kodak Company method, developed prior to established guidelines. The results of this study are valid for classification insofar as the conditions of exposure are at least as stringent as modern guidelines.
Data source
Reference
- Reference Type:
- other: Eastman Kodak Company Toxicology Report
- Title:
- Unnamed
- Year:
- 1 959
- Report date:
- 1965
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Deviations:
- not specified
- Principles of method if other than guideline:
- Method is an in vivo study using a group of four rats (sex, strain, and weights not available) exposed to an atmosphere containing the test substance as a dust for a period of six hours. After termination of exposure, the animals were observed for mortality and adverse clinical signs for a period of 14 days. Body weights were measured prior to exposure and at termination of the 2-week observation period.
- GLP compliance:
- no
- Remarks:
- Study conducted prior to GLPs
- Test type:
- other: Study conducted according to an internal Eastman Kodak Company laboratory method in which rats were exposed to the test substance by whole-body inhalation exposure.
- Limit test:
- no
Test material
- Reference substance name:
- 2,2,4-trimethylpentane-1,3-diol
- EC Number:
- 205-619-1
- EC Name:
- 2,2,4-trimethylpentane-1,3-diol
- Cas Number:
- 144-19-4
- Molecular formula:
- C8H18O2
- IUPAC Name:
- 2,2,4-trimethylpentane-1,3-diol
- Details on test material:
- -Identity (according to study report): 2,2,4-trimethyl-1,3-pentanediol (TMPD)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- no data
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- Rats were exposed (whole-body) to an atmosphere containing 4.5 mg/L of the test substance for a period of six hours. The atmosphere was generated by a Wright Dust Mill which produced a dust particulate of the test substance; the dust was mixed with air and was directed into an 18.5 L exposure chamber at the rate of 5 L/min. The chamber temperature was maintained at 25 °C.
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 6 h
- Concentrations:
- 4.5 mg/L
- No. of animals per sex per dose:
- 4 (sex not specified)
- Control animals:
- no
- Details on study design:
- Four rats (sex, strain, and weights not available) were exposed (whole-body) to an atmosphere containing 4.5 mg/L of the test substance for a period of six hours. The atmosphere was generated by a Wright Dust Mill which produced a dust particulate of the test substance that consisted of 34.1% respirable particles. The test substance was mixed with room air and was directed into a 18.5 L exposure chamber, maintained at 25 °C, at a rate of 5 L/min. The calculated total dose respired was 2.8 g/kg bw. Animals were observed for mortality and adverse effects for a period of 14 days. Body weights were recorded prior to exposure to the test substance and at termination of the observation period.
Results and discussion
Effect levels
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- > 4.5 mg/L air
- Exp. duration:
- 6 h
- Remarks on result:
- other: The respirable concentration of the test substance was 1.43 mg/L. The calculated exposure to the respirable portion of the test substance was 2.8 g/kg bw.
- Mortality:
- None
- Clinical signs:
- other: Abnormal clinical signs included piloerection, vasodilatation and lacrimation 4 minutes into inhalation exposure and nose rubbing at 5 minutes into inhalation exposure. No other signs of toxicity were noted during the inhalation exposure and the 14-day o
- Body weight:
- All animals gained weight over the 14-day observation period (130.8 g average).
- Gross pathology:
- not performed
Any other information on results incl. tables
Particle determination was 34.1% respirable particles; the total dose respired was 2.8 g/kg bw.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- Under conditions used in this study, 2,2,4-trimethyl-1,3-pentanediol was not acutely toxic by the inhalation route in rats exposed to an atmospheric concentration of 4.5 mg/L (34.1% respirable particles; total dose respired: 2.8 g/kg bw) of air for 6 hours. Since no mortality was noted at this exposure level, the LC50 in rats was greater than 4.5 mg/L of air (effective respirable concentration: 1.43 mg/L) for 6 h. Treatment-related abnormal clinical signs were noted shortly after the start of exposure and were limited to piloerection, vasodilatation, lacrimation and nose rubbing. All animals gained weight over the observation period.
In accordance with Directive 67/548/EEC, 2,2,4-trimethyl-1,3-pentanediol is not classified for acute inhalation toxicity. Based on an acute inhalation LC50 value > 4.5 mg/L (effective respirable concentration: 1.43 mg/L) for 6 h in rats, 2,2,4-trimethyl-1,3-pentanediol is not expected to be classifiable for Acute Toxicity by the inhalation route according to the UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS) or EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) 1272/2008. Based on the type and limited number of abnormal clinical signs observed during the study, 2,2,4-trimethyl-1,3-pentanediol is not classifiable for Specific Target Organ Toxicity – Single Exposure at this exposure concentration according to the UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS) or EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) 1272/2008. - Executive summary:
In an acute inhalation toxicity study, four rats were exposed to 2,2,4-trimethyl-1,3-pentanediol at a concentration of 4.5 mg/L (effective respirable concentration: 1.43 mg/L; total respired dose: 2.8 g/kg bw) for a period of 6 hours. Under the conditions of this study, no deaths occurred and the LC50 was considered to be greater than 4.5 mg/L. Signs of toxicity included piloerection, vasodilatation, lacrimation, and nose rubbing during the first 5 minutes of inhalation exposure. No other abnormal clinical signs or signs of systemic toxicity were evident during a 14-day observation period. Based on the results of this study, 2,2,4-trimethyl-1,3-pentanediol has a low potential to cause acute toxicity by the inhalation route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.